Shopping Cart
- Remove All
- Your shopping cart is currently empty
Sonepcizumab (LT 1009) is a fully humanized monoclonal antibody against S1P, with anti-cancer activity, useful for studying metastatic renal cell carcinoma (mRCC) and preventing eye scarring after glaucoma filtration surgery.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $289 | In Stock | |
5 mg | $662 | In Stock | |
10 mg | $892 | In Stock | |
25 mg | $1,350 | In Stock | |
50 mg | $1,820 | In Stock | |
100 mg | $2,450 | In Stock |
Description | Sonepcizumab (LT 1009) is a fully humanized monoclonal antibody against S1P, with anti-cancer activity, useful for studying metastatic renal cell carcinoma (mRCC) and preventing eye scarring after glaucoma filtration surgery. |
Alias | LT 1009 |
Molecular Weight | 146.43 kDa |
Cas No. | 1031360-18-5 |
Storage | store at low temperature | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.